IL103121A - Recombinant dna-derived bordetella toxin subunit analogs - Google Patents

Recombinant dna-derived bordetella toxin subunit analogs

Info

Publication number
IL103121A
IL103121A IL10312188A IL10312188A IL103121A IL 103121 A IL103121 A IL 103121A IL 10312188 A IL10312188 A IL 10312188A IL 10312188 A IL10312188 A IL 10312188A IL 103121 A IL103121 A IL 103121A
Authority
IL
Israel
Prior art keywords
recombinant
subunit
subunits
expression
toxin
Prior art date
Application number
IL10312188A
Other languages
English (en)
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26788722&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL103121(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of IL103121A publication Critical patent/IL103121A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K2039/10—Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
IL10312188A 1987-09-04 1988-08-30 Recombinant dna-derived bordetella toxin subunit analogs IL103121A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9430787A 1987-09-04 1987-09-04
US23248288A 1988-08-17 1988-08-17
IL87608A IL87608A0 (en) 1987-09-04 1988-08-30 Recombinant dna-derived bordetella toxin subunit analogs

Publications (1)

Publication Number Publication Date
IL103121A true IL103121A (en) 1995-08-31

Family

ID=26788722

Family Applications (3)

Application Number Title Priority Date Filing Date
IL10312188A IL103121A (en) 1987-09-04 1988-08-30 Recombinant dna-derived bordetella toxin subunit analogs
IL87608A IL87608A0 (en) 1987-09-04 1988-08-30 Recombinant dna-derived bordetella toxin subunit analogs
IL103121A IL103121A0 (en) 1987-09-04 1992-09-09 Recombinant dna-derived bordetella toxin subunit analogs

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL87608A IL87608A0 (en) 1987-09-04 1988-08-30 Recombinant dna-derived bordetella toxin subunit analogs
IL103121A IL103121A0 (en) 1987-09-04 1992-09-09 Recombinant dna-derived bordetella toxin subunit analogs

Country Status (16)

Country Link
US (1) US5773600A (de)
EP (2) EP0306318B2 (de)
JP (1) JP2918895B2 (de)
KR (1) KR0168039B1 (de)
CN (1) CN1033866C (de)
AT (1) ATE125568T1 (de)
CA (1) CA1341560C (de)
DE (1) DE3854213T3 (de)
DK (1) DK175821B1 (de)
ES (1) ES2076160T5 (de)
FI (1) FI101632B (de)
GR (1) GR3017497T3 (de)
IE (1) IE69753B1 (de)
IL (3) IL103121A (de)
NO (2) NO301844B1 (de)
WO (1) WO1989001976A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1223334B (it) * 1987-11-02 1990-09-19 Sclavo Spa Polipeptidi immunologicamente attivi con una tossicita' alterata utili per la preparazione di un vaccino antipertosse
US5925546A (en) * 1987-11-02 1999-07-20 Chiron S.P.A. Immunologically active polypeptides with altered toxicity useful for the preparation of an antipertussis vaccine
US6713072B1 (en) * 1987-11-02 2004-03-30 Chiron S.R.L. Immunologically active polypeptides with altered toxicity useful for the preparation of an antipertussis vaccine
GB8727489D0 (en) * 1987-11-24 1987-12-23 Connaught Lab Detoxification of pertussis toxin
US5332583A (en) * 1987-11-24 1994-07-26 Connaught Laboratories Limited Vaccine containing genetically-detoxified pertussis holotoxin
US5358868A (en) * 1987-11-24 1994-10-25 Connaught Laboratories Limited Genetic detoxification of pertussis toxin
US7232671B2 (en) * 1989-02-15 2007-06-19 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Pertussis toxin gene: cloning and expression of protective antigen
CA2009991A1 (en) * 1989-02-15 1990-08-15 Witold Cieplak Pertussis toxin gene: cloning and expression of protective antigen
ATE127347T1 (de) * 1989-04-28 1995-09-15 Sclavo Spa Pertussistoxin-mutanten, dieselbe produzierende bordetella-stämme und ihre verwendung als vakzin gegen pertussis.
US5786189A (en) * 1989-11-29 1998-07-28 Smithkline Beecham Biologicals (S.A.) Vaccine
GB9326174D0 (en) * 1993-12-22 1994-02-23 Biocine Sclavo Mucosal adjuvant
US20030072774A1 (en) * 1994-06-10 2003-04-17 Diane M. Gajewczyk Proteinaceous adjuvants
CA2433502A1 (en) * 1995-05-04 1996-11-07 Aventis Pasteur Limited Acellular pertussis vaccines and methods of preparation thereof
CA2253937A1 (en) * 1996-05-10 1997-11-20 Phylomed Corporation Methods for oxidizing disulfide bonds using ozone
FR2754543B1 (fr) 1996-10-11 1998-12-31 Pasteur Institut Souche de bordetella deficiente dans la production de toxine et exprimant une proteine hydride, liposomes comprenant de la fha et leurs utilisations comme vaccins, et utilisation de la fha pour stimuler les reponses immunitaires
US6818222B1 (en) 1997-03-21 2004-11-16 Chiron Corporation Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
GB0313916D0 (en) 2003-06-16 2003-07-23 Glaxosmithkline Biolog Sa Vaccine composition
EP2412816B1 (de) 2004-07-26 2014-12-03 Pfenex Inc. Verfahren zur verbesserten Proteinexpression durch Strain-Engineering
US8048433B2 (en) * 2004-12-17 2011-11-01 Nvi Nederlands Vaccininstituut Deacylation of LPS in gram negative bacteria
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
EP2615172A1 (de) 2007-04-27 2013-07-17 Pfenex Inc. Schnellscreeningverfahren für Bakterienwirte zur Identifizierung bestimmter Stämme mit verbessertem Ertrag und/oder verbesserter Qualität bei der Expression heterologer Proteine
ITMI20090946A1 (it) 2009-05-28 2010-11-29 Novartis Ag Espressione di proteine ricombinanti
CN102869778B (zh) 2010-03-30 2015-05-20 菲尼克斯公司 重组毒素蛋白的高水平表达
US9169304B2 (en) 2012-05-01 2015-10-27 Pfenex Inc. Process for purifying recombinant Plasmodium falciparum circumsporozoite protein
WO2014024026A1 (en) 2012-08-06 2014-02-13 Glaxosmithkline Biologicals S.A. Method for eliciting in infants an immune response against rsv and b. pertussis
US20140037680A1 (en) 2012-08-06 2014-02-06 Glaxosmithkline Biologicals, S.A. Novel method
EP2863943B1 (de) 2013-03-08 2016-07-13 Crucell Holland B.V. Nicht zellulärer pertussis-impfstoff
KR20160040290A (ko) 2013-08-05 2016-04-12 글락소스미스클라인 바이오로지칼즈 에스.에이. 조합 면역원성 조성물
CN109172818B (zh) * 2018-08-02 2021-10-22 浙江康佰裕生物科技有限公司 一种蛋白牛痘疫苗及其效力检测方法
JP2022508713A (ja) * 2018-10-15 2022-01-19 アリゾナ ボード オブ リージェンツ オン ビハーフ オブ ザ ユニバーシティ オブ アリゾナ ワクチンポリペプチド組成物および方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4704362A (en) * 1977-11-08 1987-11-03 Genentech, Inc. Recombinant cloning vehicle microbial polypeptide expression
FR2590483B1 (fr) * 1985-11-22 1988-12-09 Pasteur Institut Antigenes purifies ayant des proprietes vaccinantes contre b. pertussis, moyens notamment adns recombinants pour les produire et compositions de vaccins les contenant
CA1340373C (en) * 1986-01-28 1999-02-02 Rino Rappuoli Cloning and sequencing of the dna fragment which codes for the five subunits of the pertussis toxin, a hybrid plasmid containing the dna fragment and micro-organisms transformed by the hybrid plasmid and capable of expressing all or some of the subunits of the pertussis toxin
ES2044959T3 (es) * 1986-12-23 1994-01-16 Univ Leland Stanford Junior Exotoxina de tos ferina modificada.
IT1223334B (it) * 1987-11-02 1990-09-19 Sclavo Spa Polipeptidi immunologicamente attivi con una tossicita' alterata utili per la preparazione di un vaccino antipertosse
GB8727489D0 (en) * 1987-11-24 1987-12-23 Connaught Lab Detoxification of pertussis toxin
IT1223529B (it) * 1987-12-18 1990-09-19 Sclavo Spa Epitopo immunodominante protettivo contenuto nella subunita' s1 della tossina della pertosse

Also Published As

Publication number Publication date
IE69753B1 (en) 1996-10-02
DK175821B1 (da) 2005-03-14
DK216289A (da) 1989-06-30
NO891842L (no) 1989-06-21
FI101632B1 (fi) 1998-07-31
CN1033866C (zh) 1997-01-22
KR0168039B1 (ko) 1999-01-15
NO972642L (no) 1997-07-28
EP0629696A1 (de) 1994-12-21
NO325016B1 (no) 2008-01-14
DE3854213T3 (de) 2004-10-21
NO301844B1 (no) 1997-12-15
FI892131L (fi) 1989-05-03
NO891842D0 (no) 1989-05-03
EP0306318B1 (de) 1995-07-26
JP2918895B2 (ja) 1999-07-12
NO972642D0 (no) 1997-06-09
DE3854213T2 (de) 1995-12-07
ES2076160T5 (es) 2004-12-01
AU2386488A (en) 1989-03-31
EP0306318A1 (de) 1989-03-08
IL103121A0 (en) 1993-02-21
DE3854213D1 (de) 1995-08-31
IE882668L (en) 1989-03-04
GR3017497T3 (en) 1995-12-31
AU623867B2 (en) 1992-05-28
FI101632B (fi) 1998-07-31
JPH04501051A (ja) 1992-02-27
KR890701758A (ko) 1989-12-21
DK216289D0 (da) 1989-05-03
IL87608A0 (en) 1989-01-31
WO1989001976A1 (en) 1989-03-09
US5773600A (en) 1998-06-30
CN1033072A (zh) 1989-05-24
ES2076160T3 (es) 1995-11-01
FI892131A0 (fi) 1989-05-03
EP0306318B2 (de) 2004-04-28
CA1341560C (en) 2007-10-30
ATE125568T1 (de) 1995-08-15

Similar Documents

Publication Publication Date Title
US5773600A (en) DNA encoding pertussis toxin muteins
AU665013B2 (en) Recombinant DNA-derived cholera toxin subunit analogs
EP0652962B1 (de) Expression rekombinanter fusionsproteine in attenuierten bakterien
US7115725B2 (en) Multi-mutant diphtheria toxin vaccines
EP0712442B1 (de) Rekombinante tetc-fusionsprotein enthaltene impfstoffzusammensetzungen
Burnette et al. Direct expression of Bordetelia pertussis toxin subunits to high levels in Escherichia coli
US6841358B1 (en) Recombinant proteins of filamentous haemagglutinin of bordetella, particularly bordetella pertussis, method for producing same, and uses thereof for producing foreign proteins of vaccinating active principles
Petersen et al. Recombinant derivatives of Pasteurella multocida toxin: candidates for a vaccine against progressive atrophic rhinitis
Cieplak et al. Identification of a region in the S1 subunit of pertussis toxin that is required for enzymatic activity and that contributes to the formation of a neutralizing antigenic determinant.
US6994854B1 (en) Protective epitopes of adenyl cyclase-haemolysin (AC-Hly), their application to the treatment or to the prevention of bordetella infections
US7144576B1 (en) Modified pertussis toxin
AU623867C (en) Recombinant DNA-derived bordetella toxin subunit analogs
Makoff et al. Recombinant Antigens as Components of a Diphtheria-Tetanys-PerSüssis Vaccine
Agron Foot-and-mouth-disease virus antigens-comprising peptides with amino acid sequence of viral protein antigenic sites
WO1992017587A1 (en) Bordetella bronchiseptica outer membrane antigen
US20030044891A1 (en) Pertussis toxin gene: cloning and expression of protective antigen

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
RH Patent void
KB Patent renewed
KB Patent renewed
EXP Patent expired
EXP Patent expired